CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation

Journal of Nutritional Biochemistry

Volumn 27, Issue , 2016, Pages 43-52

  Han, Sora ^a   Park, Jeong Su ^a   Lee, Sunyi ^a   Jeong, Ae Lee ^a   Oh, Ki Sook ^a   Ka, Hye In ^a   Choi, Hyun Ji ^b   Son, Woo Chan ^b   Lee, Won Young ^c   Oh, Suk Joong ^c   Lim, Jong Seok ^a   Lee, Myeong Sok ^a   Yang, Young ^a  

^a Sookmyung Women's University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c School of Medicine   (South Korea)

Author keywords

Fatty acid oxidation; Glycolysis; High fat diet; High sucrose diet; Hyperglycemia; Insulin resistance

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; BETA ACTIN; COMPLEMENT C1Q TUMOR NECROSIS FACTOR ALPHA RELATED PROTEIN 1; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOPROTEIN; HORMONE SENSITIVE LIPASE; UNCLASSIFIED DRUG; ADIPOCYTOKINE; CTRP1 PROTEIN, MOUSE; FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MAJOR CLINICAL STUDY; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; TRANSGENIC MOUSE; 3T3 CELL LINE; ANIMAL; DIET; ENERGY METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SKELETAL MUSCLE;

3T3-L1 CELLS; ADIPOKINES; ANIMALS; DIET; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY ACIDS; GLYCOLYSIS; HYPERGLYCEMIA; MICE; MUSCLE, SKELETAL; OXIDATION-REDUCTION;

EID: 84952760651     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.08.018     Document Type: Article

References (42)

1. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
2. Al-Khalili L., Chibalin A.V., Kannisto K., Zhang B.B., Permert J., Holman G.D., et al. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 2003, 60:991-998.
3. Huang C., Somwar R., Patel N., Niu W., Torok D., Klip A. Sustained exposure of L6 myotubes to high glucose and insulin decreases insulin-stimulated GLUT4 translocation but upregulates GLUT4 activity. Diabetes 2002, 51:2090-2098.
4. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999, 19:4008-4018.
5. Cong L.N., Chen H., Li Y., Zhou L., McGibbon M.A., Taylor S.I., et al. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 1997, 11:1881-1890.
6. Kohn A.D., Summers S.A., Birnbaum M.J., Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996, 271:31372-31378.
7. Qatanani M., Lazar M.A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 2007, 21:1443-1455.
8. Liu Y., Michael M.D., Kash S., Bensch W.R., Monia B.P., Murray S.F., et al. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 2007, 148:683-692.
9. Liu Y., Turdi S., Park T., Morris N.J., Deshaies Y., Xu A., et al. Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. Diabetes 2013, 62:743-752.
10. Kowalska I., Straczkowski M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 2007, 22:1824-1829.
11. Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 2010, 44:25-36.
12. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
13. Thomson D.M., Winder W.W. AMP-activated protein kinase control of fat metabolism in skeletal muscle. Acta Physiol (Oxf) 2009, 196:147-154.
14. Kajita K., Mune T., Ikeda T., Matsumoto M., Uno Y., Sugiyama C., et al. Effect of fasting on PPARgamma and AMPK activity in adipocytes. Diabetes Res Clin Pract 2008, 81:144-149.
15. Carracedo A., Cantley L.C., Pandolfi P.P. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 2013, 13:227-232.
16. Watt M.J., Holmes A.G., Pinnamaneni S.K., Garnham A.P., Steinberg G.R., Kemp B.E., et al. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 2006, 290:E500-E508.
17. Gaidhu M.P., Anthony N.M., Patel P., Hawke T.J., Ceddia R.B. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol 2010, 298:C961-C971.
18. Goodpaster B.H., Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr Diabetes 2004, 5:219-226.
19. Wong G.W., Krawczyk S.A., Kitidis-Mitrokostas C., Revett T., Gimeno R., Lodish H.F. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 2008, 416:161-177.
20. Wong G.W., Wang J., Hug C., Tsao T.S., Lodish H.F. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A 2004, 101:10302-10307.
21. Kim K.Y., Kim H.Y., Kim J.H., Lee C.H., Kim D.H., Lee Y.H., et al. Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 2006, 580:3953-3960.
22. Jeon J.H., Kim K.Y., Kim J.H., Baek A., Cho H., Lee Y.H., et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J 2008, 22:1502-1511.
23. Chalupova L., Zakovska A., Adamcova K. Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem 2013, 46:73-78.
24. Pan X., Lu T., Wu F., Jin L., Zhang Y., Shi L., et al. Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS One 2014, 9:e94478.
25. Xin Y., Lyu X., Wang C., Fu Y., Zhang S., Tian C., et al. Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocr J 2014, 61:841-847.
26. Shen Y., Lu L., Liu Z.H., Wu F., Zhu J.Z., Sun Z., et al. Increased serum level of CTRP1 is associated with low coronary collateralization in stable angina patients with chronic total occlusion. Int J Cardiol 2014, 174:203-206.
27. Yuasa D., Ohashi K., Shibata R., Takeshita K., Kikuchi R., Takahashi R., et al. Association of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men. PLoS One 2014, 9:e99846.
28. Lasser G., Guchhait P., Ellsworth J.L., Sheppard P., Lewis K., Bishop P., et al. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood 2006, 107:423-430.
29. Akiyama H., Otani M., Sato S., Toyosawa S., Furukawa S., Wakisaka S., et al. A novel adipokine C1q/TNF-related protein 1 (CTRP1) regulates chondrocyte proliferation and maturation through the ERK1/2 signaling pathway. Mol Cell Endocrinol 2013, 369:63-71.
30. Peterson J.M., Aja S., Wei Z., Wong G.W. CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem 2012, 287:1576-1587.
31. Seldin M.M., Tan S.Y., Wong G.W. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord 2014, 15:111-123.
32. Han S., Oh K.S., Yoon Y., Park J.S., Park Y.S., Han J.H., et al. Herbal extract THI improves metabolic abnormality in mice fed a high-fat diet. Nutr Res Pract 2011, 5:198-204.
33. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
34. Han S., Jeong A.L., Lee S., Park J.S., Kim K.D., Choi I., et al. Adiponectin deficiency suppresses lymphoma growth in mice by modulating NK cells, CD8 T cells, and myeloid-derived suppressor cells. J Immunol 2013, 190:4877-4886.
35. Feige J.N., Lagouge M., Canto C., Strehle A., Houten S.M., Milne J.C., et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008, 8:347-358.
36. Huang J.P., Huang S.S., Deng J.Y., Hung L.M. Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats. J Biomed Sci 2009, 16:77.
37. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab 2007, 5:237-252.
38. Washington T.A., Healey J.M., Thompson R.W., Lowe L.L., Carson J.A. Lactate dehydrogenase regulation in aged skeletal muscle: regulation by anabolic steroids and functional overload. Exp Gerontol 2014, 57C:66-74.
39. Burkewitz K., Zhang Y., Mair W.B. AMPK at the nexus of energetics and aging. Cell Metab 2014, 20:10-25.
40. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006, 86:205-243.
41. Munday M.R., Hemingway C.J. The regulation of acetyl-CoA carboxylase - a potential target for the action of hypolipidemic agents. Adv Enzyme Regul 1999, 39:205-234.
42. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang Cc C., Itani S.I., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 2002, 99:16309-16313.